Biosimilar Symposium
Upcoming

  • June 5, 2018
    8:30 am - 5:00 pm

Location

6250 Highway 7, Vaughan, Ontario, Canada, L4H 4G3
C

Certification Areas

Join us June 5th at the Universal EventSpace in Toronto, ON! Hear directly from regulators through an exclusive line up of Health Canada’s Biologics & Genetic Therapies Directorate (BGTD) department as well as the FDA.

 

More details to follow!

Here’s a SNEAK PEAK at our Symposium Program and speakers!

 

Topic 1: Biosimilars Regulation & Update on Key Activities

Emily Griffiths
Subject Matter/Technical Specialist
Office of Policy and International Collaboration
Biologics and Genetic Therapies Directorate

 

Topic 2: Best Practices when Filing Biosimilar Submissions

Jemma Fraije
Regulatory Affairs Supervisor
Office of Regulatory Affairs
Biologics and Genetic Therapies Directorate

 

Topic 3: Quality Evaluation of Biosimilars

Dr. Wallace Lauzon
Chief, Cytokines Division
Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics
Biologics and Genetic Therapies Directorate

 

Topic 4: TBC

Dr. Sue Lim
Medical Officer, Team Leader
Office of New Drugs Therapeutics Biologics and Biosimilars Staff
Centre for Drug Evaluation and Research
U.S. Food and Drug Administration

 

Topic 5: Non-Clinical & Clinical Evaluations of Biosimilars

Dr. Jian Wang
Chief, Clinical Evaluation Division
Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics
Biologics and Genetic Therapies Directorate



PSG Member: $545.00 On Sale
PSG Non-Member: $595.00 On Sale
Corporate +5: $500.00 On Sale
Corporate +10: $450.00 On Sale
Health Canada: $500.00 On Sale
Student: $200.00 On Sale